Iveta Kudaba

13.0k citations
24 papers · 779 · 1 hit paper · h-index 14

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 10
    • Lung Cancer Research Studies 5
    • Lung Cancer Treatments and Mutations 5
    • Gastric Cancer Management and Outcomes 5
    • Lung Cancer Diagnosis and Treatment 3

Iveta Kudaba

23 papers receiving 769 citations

Iveta Kudaba's Hit Papers

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study 2022 · 169 citations
1690+1+2Years since publication50100150

Peers

Iveta Kudaba
Comparison fields: 5 of 48
  • Oncology 553
  • Gastroenterology 68
  • Pulmonary and Respiratory Medicine 332
  • Cancer Research 55
  • Immunology 69
Replace Eduardo Yañez Ruiz with:
Eduardo Yañez Ruiz United States
Rita P. Dalal United States
Salah-Eddin Al-Batran Germany
Matías Chacón Argentina
Nami Hirano Japan
Takashi Ichimura Japan
Keishi Okubo Japan
Hideki Kamada Japan
Yuichi Mikamoto Japan
Betsy Althaus United States
Iveta Kudaba relative to Eduardo Yañez Ruiz United States Eduardo Yañez Ruiz's profile →
Citations per field
00.5×1.5×2.3×
Eduardo Yañez Ruiz · 1×
Citations per year

Countries citing papers authored by Iveta Kudaba

Since Specialization
Citations

This map shows the geographic impact of Iveta Kudaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iveta Kudaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iveta Kudaba more than expected).

Fields of papers citing papers by Iveta Kudaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iveta Kudaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iveta Kudaba. The network helps show where Iveta Kudaba may publish in the future.

Co-authors

The 25 scholars most cited alongside Iveta Kudaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iveta Kudaba Line = papers co-authored together Iveta Kudaba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Hit paper breakdown →
2022169
2 2018138
3 2019131
4 202061
5 202260
6 201932
7 201922
8 202121
9 201820
10 201319
11 202218
12 200518
13 201916
14 202115
15 202112
16 202011
17 20196
18 20193
19 20122
20 20111

About Iveta Kudaba

Iveta Kudaba is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Epidemiology, having authored 24 papers that have together received 779 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (553 citations), Gastroenterology (68 citations), Pulmonary and Respiratory Medicine (332 citations), Cancer Research (55 citations) and Immunology (69 citations). Iveta Kudaba has collaborated with scholars based in Latvia, United States and Japan. Frequent co-authors include Igor Bondarenko, Gilberto de Castro, Byoung Chul Cho, Dariusz M. Kowalski, Yi‐Long Wu, Tony Mok, Vichien Srimuninnimit, Marcelo Garrido, Zev A. Wainberg and Joseph Chao. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, International Journal of Cancer, Journal of Thoracic Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact